BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI).
CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain and bruising compared to alternative laser treatment therapy.